Inventor · disambiguated record
William C. Patt
Also filed as: PATT WILLIAM · PATT WILLIAM C · PATT WILLIAM CHESTER
43 granted patents·5 pending applications·793 citations·filing 1985–2015
98Inventor score
Top patents by PatentIndex Score
48 records- 0197US9309224B2N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Apr 12, 2016·60 cites·40 claims
- 0297US9187474B2Raf inhibitor compoundsDECIPHERA PHARMACEUTICALS LLC·Filed 2013·Granted Nov 17, 2015·60 cites·19 claims
- 0397US8188113B2Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseasesFLYNN DANIEL L·Filed 2007·Granted May 29, 2012·74 cites·19 claims
- 0497US7897762B2Kinase inhibitors useful for the treatment of proliferative diseasesDECIPHERA PHARMACEUTICALS LLC·Filed 2007·Granted Mar 1, 2011·59 cites·93 claims
- 0596US9133183B2Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Sep 15, 2015·60 cites·32 claims
- 0695US9382228B2N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Jul 5, 2016·60 cites·43 claims
- 0795US5036053ADiol-containing renin inhibitorsWARNER LAMBERT CO·Filed 1989·Granted Jul 30, 1991·130 cites·12 claims
- 0887US5691373ANonpeptide endothelin antagonists IWARNER LAMBERT CO·Filed 1995·Granted Nov 25, 1997·36 cites·10 claims
- 0981US7504389B2Protein tyrosine phosphatase inhibitors and methods of use thereofCEPTYR INC·Filed 2005·Granted Mar 17, 2009·7 cites·11 claims
- 1081US4738954ANovel N6 -substituted-5'-oxidized adenosine analogsWARNER LAMBERT CO·Filed 1985·Granted Apr 19, 1988·30 cites·15 claims
- 1175US7829737B2Protein tyrosine phosphatase inhibitors and methods of use thereofCEPTYR INC·Filed 2008·Granted Nov 9, 2010·2 cites·3 claims
- 1275US6017916ANonpeptide endothelin antagonists IWARNER LAMBERT CO·Filed 1997·Granted Jan 25, 2000·17 cites·2 claims
- 1374US7015237B2Pyridine matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2004·Granted Mar 21, 2006·6 cites·5 claims
- 1474US6686355B2Biphenyl sulfonamides useful as matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Feb 3, 2004·7 cites·28 claims
- 1574US6017951AButenolide endothelin antagonistsWARNER LAMBERT CO·Filed 1999·Granted Jan 25, 2000·18 cites·2 claims
- 1673US6133263AEndothelin antagonists with ether-linked groupsWARNER LAMBERT CO·Filed 1997·Granted Oct 17, 2000·16 cites·30 claims
- 1773US5891892ASmall molecule biaryl compounds as inhibitors of endothelin converting enzymeWARNER LAMBERT CO·Filed 1997·Granted Apr 6, 1999·16 cites·4 claims
- 1872US7205295B2Benzoxazin-3-ones and derivatives thereof as therapeutic agentsWARNER LAMBERT CO·Filed 2003·Granted Apr 17, 2007·8 cites·19 claims
- 1971US6043241AKetoacid endothelin antagonistsWARNER LAMBERT CO·Filed 1997·Granted Mar 28, 2000·16 cites·32 claims
- 2070US4791103A2,N6 -disubstituted adenosines, derivatives and methods of useWARNER LAMBERT CO·Filed 1985·Granted Dec 13, 1988·17 cites·48 claims
- 2168US6936616B2Pyrimidine matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Aug 30, 2005·4 cites·9 claims
- 2265US6559142B2Sulfonamide matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2002·Granted May 6, 2003·2 cites·16 claims
- 2364US6995151B2Isophthalic acid derivatives as matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Feb 7, 2006·2 cites·8 claims
- 2464US5219851ATetrahydroisoquinoline-type renin inhibiting peptidesWARNER LAMBERT CO·Filed 1991·Granted Jun 15, 1993·8 cites·17 claims
- 2563US6881743B2Pyridine matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Apr 19, 2005·1 cites·13 claims
- 2663US4600707ABenzothien-3-yl adenosine; benzothien-3-yl adenosine, S-oxide; and benzothien-3-yl, S,S-dioxide adenosine compoundsWARNER LAMBERT CO·Filed 1985·Granted Jul 15, 1986·12 cites·14 claims
- 2762US6297274B1Nonpeptide endothelin antagonists with increased water solubilityWARNER LAMBERT CO·Filed 1997·Granted Oct 2, 2001·9 cites·29 claims
- 2861US6906094B21,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenaseWARNER LAMBERT CO·Filed 2001·Granted Jun 14, 2005·1 cites·16 claims
- 2960US2009131374A1Protein tyrosine phosphatase inhibitors and methods of use thereofCEPTYR INC·Filed 2009·Application pending·0 cites
- 3059US5998468AFuranone endothelin antagonistsWARNER LAMBERT CO·Filed 1996·Granted Dec 7, 1999·7 cites·6 claims
- 3156US4868160AMethod of treating psychosis using N6 -substituted -5'-oxidized adenosine analogsWARNER LAMBERT CO·Filed 1987·Granted Sep 19, 1989·9 cites·1 claims
- 3255US4614732AN6 -acenaphthyl adenosines and analogs thereofWARNER LAMBERT CO·Filed 1985·Granted Sep 30, 1986·8 cites·12 claims
- 3354US6017918APhenyl glycine compounds and methods of treating atherosclerosis and restenosisWARNER LAMBERT CO·Filed 1999·Granted Jan 25, 2000·5 cites·22 claims
- 3450US7214712B2Isophthalic acid derivatives as matrix metalloproteinase inhibitorsWARNER LAMBERT CO·Filed 2005·Granted May 8, 2007·0 cites·1 claims
- 3550US4616003AN6 -dihydroxypropyladenosinesWARNER LAMBERT CO·Filed 1985·Granted Oct 7, 1986·6 cites·15 claims
- 3649US2012289540A1Kinase inhibitors useful for the treatment of proliferative diseasesFLYNN DANIEL L·Filed 2012·Application pending·0 cites
- 3749US2016046619A1Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 3846US2011118271A1Kinase Inhibitors Useful For The Treatment Of Proliferative DiseasesFLYNN DANIEL L·Filed 2011·Application pending·0 cites
- 3944US5238923AAmino-substituted heterocycles as renin inhibitorsWARNER LAMBERT CO·Filed 1990·Granted Aug 24, 1993·4 cites·4 claims
- 4043US5260278ADiol-containing renin inhibitorsWARNER LAMBERT CO·Filed 1991·Granted Nov 9, 1993·6 cites·7 claims
- 4142US5135914ASubstituted derivatives of 3-amino-2-hydroxypropionic acid as inhibitors of reninWARNER LAMBERT CO·Filed 1988·Granted Aug 4, 1992·1 cites·6 claims
- 4242US4764506AN6 -(benzothien-3-yl)ethyl adenosine; N6 -(benzothien-3-yl)ethyl adenosine, S-oxide; and N6 -(benzothien-3-yl)ethyl S,S-dioxide adenosineWARNER LAMBERT CO·Filed 1986·Granted Aug 16, 1988·3 cites·12 claims
- 4342US4636493ABenzothien-3-yl adenosine; benzothien-3-yl adenosine, S-oxide; and benzothien-3-yl, S,S-dioxide adenosine compoundsWARNER LAMBERT CO·Filed 1986·Granted Jan 13, 1987·3 cites·12 claims
- 4439US2002193377A1Quinazolines as MMP-13 inhibitorsFiled 2002·Application pending·0 cites
- 4538US4673670AN6 -acenaphthyl adenosines and analogs thereofWARNER LAMBERT CO·Filed 1986·Granted Jun 16, 1987·2 cites·10 claims
- 4637US5922759AButenolide endothelin antagonistsWARNER LAMBERT CO·Filed 1996·Granted Jul 13, 1999·1 cites·9 claims
- 4731US5643879AAmino-substituted heterocycles as renin inhibitorsWARNER LAMBERT CO·Filed 1995·Granted Jul 1, 1997·0 cites·24 claims
- 4831US5453488AAmino-substituted heterocycles as renin inhibitorsWARNER LAMBERT CO·Filed 1993·Granted Sep 26, 1995·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when William C. Patt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →